Full Text
Use of Molecular testing prior to first-line Erlotinib Therapy among medicare patients with stage IV non-small Cell Lung Cancer

Abstract

Authors

D. Romanus D. Cutler N.L. Keating I.T. Lennes E. Lamont G.S. Gazelle M.B. Landrum

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×